Familial hypercholesterolemia – treatment update in children, systematic review

Sabina Ziółkowska; Noëlle Kijek; Iga Zendran; Ewa Szuster; Ewa Barg

doi:10.5114/pedm.2022.116112

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

2/2022
vol. 28

Send email

Copy url:

abstract:

Review paper

Familial hypercholesterolemia – treatment update in children, systematic review

Sabina Ziółkowska

¹

,

Noëlle Kijek

¹

,

Iga Zendran

¹

,

Ewa Szuster

¹

,

Ewa Barg

²

Graduate of Wroclaw Medical University, Poland
Department of Basic Medical Sciences, Wroclaw Medical University, Poland

Pediatr Endocrinol Diabetes Metab 2022; 28 (2): 152–161

DOI: https://doi.org/10.5114/pedm.2022.116112

Online publish date: 2022/06/28

View full text Get citation

PlumX metrics:

Familial hypercholesterolaemia is one of the most common genetic diseases, and its first symptoms occur in childhood. Proper diagnosis and treatment prevent young patients from severe consequences in their future. The treatment of this dyslipidaemia is still evolving, and new promising agents are being discovered. In this review we summarize the old and new treatment methods of familial hypercholesterolaemia, giving an update estimated on the latest publications.

keywords:

Familial hypercholesterolemia – treatment update in children, systematic review

Sabina Ziółkowska 1 , Noëlle Kijek 1 , Iga Zendran 1 , Ewa Szuster 1 , Ewa Barg 2

hypercholesterolaemia, children, adolescents, hyperlipoproteinaemia, cholesterol

Sabina Ziółkowska

¹

,

Noëlle Kijek

¹

,

Iga Zendran

¹

,

Ewa Szuster

¹

,

Ewa Barg

²